144 related articles for article (PubMed ID: 18941256)
1. Bone marrow-derived IFN-producing killer dendritic cells account for the tumoricidal activity of unpulsed dendritic cells.
Himoudi N; Nabarro S; Buddle J; Eddaoudi A; Thrasher AJ; Anderson J
J Immunol; 2008 Nov; 181(9):6654-63. PubMed ID: 18941256
[TBL] [Abstract][Full Text] [Related]
2. Migratory and antigen presentation functions of IFN-producing killer dendritic cells.
Himoudi N; Yan M; Bouma G; Morgenstern D; Wallace R; Seddon B; Buddle J; Eddaoudi A; Howe SJ; Cooper N; Anderson J
Cancer Res; 2009 Aug; 69(16):6598-606. PubMed ID: 19654308
[TBL] [Abstract][Full Text] [Related]
3. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells.
Vosshenrich CA; Lesjean-Pottier S; Hasan M; Richard-Le Goff O; Corcuff E; Mandelboim O; Di Santo JP
J Exp Med; 2007 Oct; 204(11):2569-78. PubMed ID: 17923507
[TBL] [Abstract][Full Text] [Related]
4. Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-γ-dependent mechanism.
LaCasse CJ; Janikashvili N; Larmonier CB; Alizadeh D; Hanke N; Kartchner J; Situ E; Centuori S; Har-Noy M; Bonnotte B; Katsanis E; Larmonier N
J Immunol; 2011 Dec; 187(12):6310-7. PubMed ID: 22075702
[TBL] [Abstract][Full Text] [Related]
5. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
[TBL] [Abstract][Full Text] [Related]
7. IL-15 Generates IFN-γ-producing Cells Reciprocally Expressing Lymphoid-Myeloid Markers during Dendritic Cell Differentiation.
Kwon KW; Kim SJ; Kim H; Kim WS; Kang SM; Choi E; Ha SJ; Yoon JH; Shin SJ
Int J Biol Sci; 2019; 15(2):464-480. PubMed ID: 30745835
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
Winter H; Hu HM; McClain K; Urba WJ; Fox BA
J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
[TBL] [Abstract][Full Text] [Related]
9. IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma.
Jiang Q; Wei H; Tian Z
J Immunother; 2008; 31(6):555-62. PubMed ID: 18528299
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells.
Ribas A; Wargo JA; Comin-Anduix B; Sanetti S; Schumacher LY; McLean C; Dissette VB; Glaspy JA; McBride WH; Butterfield LH; Economou JS
J Immunol; 2004 Apr; 172(8):4762-9. PubMed ID: 15067052
[TBL] [Abstract][Full Text] [Related]
11. Natural killer dendritic cells are an intermediate of developing dendritic cells.
Chen L; Calomeni E; Wen J; Ozato K; Shen R; Gao JX
J Leukoc Biol; 2007 Jun; 81(6):1422-33. PubMed ID: 17332372
[TBL] [Abstract][Full Text] [Related]
12. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
[TBL] [Abstract][Full Text] [Related]
13. The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
Terme M; Mignot G; Ullrich E; Bonmort M; Minard-Colin V; Jacquet A; Schultze JL; Kroemer G; Leclerc C; Chaput N; Zitvogel L
Cancer Res; 2009 Aug; 69(16):6590-7. PubMed ID: 19679551
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-induced activation of adaptive and innate antitumor immunity.
van den Broeke LT; Daschbach E; Thomas EK; Andringa G; Berzofsky JA
J Immunol; 2003 Dec; 171(11):5842-52. PubMed ID: 14634094
[TBL] [Abstract][Full Text] [Related]
15. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells.
Blasius AL; Barchet W; Cella M; Colonna M
J Exp Med; 2007 Oct; 204(11):2561-8. PubMed ID: 17923504
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow.
Yang S; Darrow TL; Vervaert CE; Seigler HF
Cell Immunol; 1997 Jul; 179(1):84-95. PubMed ID: 9259775
[TBL] [Abstract][Full Text] [Related]
17. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
Stober D; Jomantaite I; Schirmbeck R; Reimann J
J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
[TBL] [Abstract][Full Text] [Related]
18. Trans-presentation of IL-15 dictates IFN-producing killer dendritic cells effector functions.
Ullrich E; Bonmort M; Mignot G; Jacobs B; Bosisio D; Sozzani S; Jalil A; Louache F; Bulanova E; Geissman F; Ryffel B; Chaput N; Bulfone-Paus S; Zitvogel L
J Immunol; 2008 Jun; 180(12):7887-97. PubMed ID: 18523252
[TBL] [Abstract][Full Text] [Related]
19. A novel dendritic cell subset involved in tumor immunosurveillance.
Taieb J; Chaput N; Ménard C; Apetoh L; Ullrich E; Bonmort M; Péquignot M; Casares N; Terme M; Flament C; Opolon P; Lecluse Y; Métivier D; Tomasello E; Vivier E; Ghiringhelli F; Martin F; Klatzmann D; Poynard T; Tursz T; Raposo G; Yagita H; Ryffel B; Kroemer G; Zitvogel L
Nat Med; 2006 Feb; 12(2):214-9. PubMed ID: 16444265
[TBL] [Abstract][Full Text] [Related]
20. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.
Cao X; Zhang W; He L; Xie Z; Ma S; Tao Q; Yu Y; Hamada H; Wang J
J Immunol; 1998 Dec; 161(11):6238-44. PubMed ID: 9834111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
